Latest Technology News

PlaySide Studios has released its unaudited FY25 results, showing revenues just below guidance and an EBITDA loss within expectations amid restructuring. The company remains optimistic about revenue growth and cost savings in FY26, pending the launch of its new title.

Loyal Metals has partnered with veteran geologist Dr. Simon Beams to unlock the untapped copper-gold potential of the historic Highway Reward Mine using advanced AI and modern exploration techniques.

Thunderbird Resources reports further high-grade gold assay results from its Kookabookra Project in NSW, revealing new target areas and preparing for maiden drilling later this year.

Gold Mountain Limited has outlined a significant Exploration Target at its Irajuba Prospect in Brazil, confirming high-grade rare earth mineralisation and setting the stage for imminent diamond drilling.

Nanoveu Limited has completed a $2 million capital raise through a strategic placement and exercised options, reinforcing its position in advanced semiconductor and 3D visualization technologies.

Firebird Metals has secured two key patents for its proprietary Lithium Manganese Iron Phosphate (LMFP) battery materials, reinforcing its position in the emerging $20 billion LMFP market. The company’s integrated production approach and expanding IP portfolio set the stage for global growth amid shifting technology controls.

Kula Gold has initiated exploration at its Wozi Niobium Project in Malawi, aiming to validate historic surface mineralisation and progress towards a maiden drilling campaign by December 2025. This move diversifies the company’s portfolio beyond gold into critical minerals with promising regional infrastructure.

Pentanet Limited has secured a $2 million finance facility to fund the final payment for its 5G spectrum licence, reinforcing its growth strategy in telecommunications and cloud gaming.

Connexion Mobility reported steady revenue growth and a 7% increase in net profit before tax for Q4 FY25, driven by expanding SaaS subscriptions and strategic product enhancements.

Mesoblast has reported a strong commercial debut for Ryoncil, the first FDA-approved mesenchymal stromal cell therapy for pediatric steroid-refractory acute graft-versus-host disease, generating US$13.2 million in gross revenue in its initial quarter. The company is advancing regulatory and clinical milestones while expanding insurance coverage across the US.

American Rare Earths is progressing its Halleck Creek Rare Earths Project with multiple mineral processing optimisation tests, ordering critical equipment for a demonstration plant, and initiating test mining to secure bulk samples.

4DMedical has renewed its three-year contract with the University of Michigan Medical Center, reinforcing its foothold in US respiratory imaging. Alongside, a pivotal clinical study validates its technology’s ability to detect early lung disease, while a substantial Australian grant boosts its AI research.